Skip to main content
THC
NYSE Industrial Applications And Services

Tenet Healthcare Reports Strong Q1 Earnings, Raises Full-Year Guidance, and Repurchases $318M in Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$178.84
Mkt Cap
$15.778B
52W Low
$126.75
52W High
$247.21
52W Position info
41% above low
Off High info
28% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

THC sits 41% above its 52-week low of $126.75.

Summary

Tenet Healthcare reported a significant increase in Q1 net income and EPS, alongside strong cash flow and $318 million in share repurchases, while also providing an optimistic full-year 2026 outlook.


Key Events · Earnings and Guidance · THC

  • Strong First Quarter Financials

    Net income available to common shareholders surged 72.9% to $702 million, with diluted EPS rising 87.6% to $8.01 compared to the prior year. Adjusted diluted EPS increased 10.6% to $4.82.

  • Robust Cash Flow Generation

    Net cash flows provided by operating activities more than doubled to $1.641 billion, and adjusted free cash flow grew 44.2% to $978 million for the quarter.

  • Significant Share Repurchases

    The company repurchased 1.35 million shares of common stock for $318 million during the first quarter, reflecting strong capital allocation.

  • Updated Full-Year 2026 Outlook

    Tenet provided a comprehensive full-year outlook, projecting net operating revenues between $21.5 billion and $22.3 billion, and adjusted diluted EPS between $16.38 and $18.68.


Analysis · THC · Industrial Applications And Services

Tenet Healthcare delivered a strong first quarter, significantly increasing net income and diluted earnings per share, driven by robust operating cash flow and a favorable impact from the CommonSpirit Health agreement. The company also demonstrated a commitment to shareholder returns through substantial share repurchases. The updated full-year guidance provides a positive outlook, particularly for the Ambulatory Care segment, indicating continued operational strength and strategic execution.

How filings like this one have moved

In the 30 days to Sep 11, 2026, 36.1% of the 1758 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.05%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, THC was trading at $178.84 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $15.8B. The 52-week trading range was $126.75 to $247.21. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

THC - Latest Insights

THC
Sep 08, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $259.06
Real-time Price: $263.46 info
Change: +$4.40 (+2%) info
Market Cap: $21.214B info
THC
Sep 08, 2026, 5:00 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $259.06
Real-time Price: $263.46 info
Change: +$4.40 (+2%) info
Market Cap: $21.214B info
THC
Aug 26, 2026, 8:00 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $277.50
Real-time Price: $263.46 info
Change: -$14.04 (-5%) info
Market Cap: $21.214B info
THC
Jul 29, 2026, 4:27 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $255.00
Real-time Price: $263.46 info
Change: +$8.46 (+3%) info
Market Cap: $21.214B info
THC
Jul 23, 2026, 4:23 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $228.00
Real-time Price: $263.46 info
Change: +$35.46 (+16%) info
Market Cap: $21.214B info